Evaluation of Prognostic Factors in Children with Acute Lymphoblastic Leukemia
نویسندگان
1 Pediatric Hematologist oncologist, Department of pediatrics, School of medicine, Isfahan University of medical sciences, Isfahan, Iran - Pediatric Hematologist oncologist, Department of pediatrics, School of medicine, Isfahan University of medical sciences, Isfahan, Iran
2 Pediatrician, Department of pediatrics, School of medicine, Isfahan University of medical sciences, Isfahan, Iran - Pediatrician, Department of pediatrics, School of medicine, Isfahan University of medical sciences, Isfahan, Iran
doi
10.18502/ijpho.v16i1.20425چکیده
Background: Acute lymphoblastic leukemia (ALL) is the most common childhood malignancy. Despite major therapeutic advancements, relapse and treatment failure continue to be serious challenges, particularly in low- and middle-income countries. While several well-established prognostic factors such as age, white blood cell (WBC) count, cytogenetic abnormalities, minimal residual disease (MRD), and ...
